Congenital nephrogenic diabetes insipidus treated with acetazolamide
Wesley Du Plessis, Mogamat‐Yazied Chothia- Nephrology
- General Medicine
Abstract
Congenital nephrogenic diabetes insipidus (CNDI) is a rare disorder. The condition is characterised by an inability of distal nephron segments to respond to normal or raised concentrations of serum antidiuretic hormone. In this report, we describe the case of a 13‐year‐old male known with CNDI who experienced a pedestrian vehicle accident leading to coma following a head injury. Intra‐operatively, severe hypernatraemia and polyuria were observed. Following an inadequate response to conventional therapy, acetazolamide was prescribed resulting in an immediate response to therapy. To the best of our knowledge, acetazolamide has not been previously documented as a therapeutic option for CNDI. Additional research is necessary before considering the recommendation of acetazolamide for cases of NDI that do not respond adequately to conventional treatments.